University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Beating breast cancer: The latest on prevention and screening

Beating breast cancer: The latest on prevention and screening

October 4, 2016

There’s good news on the breast cancer front: Advances in medicine are helping more women than ever survive a breast cancer diagnosis.

Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy, Study Finds

Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy, Study Finds

August 24, 2016

Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UC San Francisco researcher.

Frequency of Breast Cancer Screening is Best Guided by Both Risk, Breast Density, Says Study

Frequency of Breast Cancer Screening is Best Guided by Both Risk, Breast Density, Says Study

August 22, 2016

The ideal interval for breast cancer screening depends on combined assessments of each woman’s breast cancer risk and her breast density, according to a new study led by UC San Francisco and University of Wisconsin (UW) researchers. The research team, members of two nationwide breast ...
UCSF Researcher Part of Consortium Awarded $7.5M to Evaluate Breast Imaging Strategies

UCSF Researcher Part of Consortium Awarded $7.5M to Evaluate Breast Imaging Strategies

June 6, 2016

Karla Kerlikowske, MD, a co-principal investigator of the Breast Cancer Surveillance Consortium(BCSC), is part of the team awarded $7.5 million by the Patient-Centered Outcomes Research Institute(PCORI) board of governors to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies.

Developments in Cancer Research and Care, from Prostate Cancer to Breast Cancer to Immunotherapy

Developments in Cancer Research and Care, from Prostate Cancer to Breast Cancer to Immunotherapy

June 1, 2016

Cancer specialists from UC San Francisco will share information on advances in research during the annual meeting of the American Society of Clinical Oncology (ASCO), one of the world’s most prestigious gatherings of oncology professionals.

Laura Esserman Named to TIME 100 List of Most Influential People in the World

Laura Esserman Named to TIME 100 List of Most Influential People in the World

April 21, 2016

Time magazine has named internationally renowned breast cancer oncologist Laura Esserman, MD, MBA, to the2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world.